PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Neighborhood stressors dangerously elevate pregnancy hormones

2023-11-03
(Press-News.org) Pregnant women living in blighted neighborhoods with high levels of known stressors have higher levels of testosterone – the primary sex hormone in males -- which disrupt hormone regulation and may lead to life-threatening complications during and after childbirth, according to Rutgers research. 

“Previous research has shown that exposure to neighborhood stressors is associated with preterm birth, low birth weight and other complications such as preeclampsia, gestational diabetes and stillbirth,” said Zorimar Rivera Núñez, an assistant professor of epidemiology at the Rutgers School of Public Health and a senior author of the study published in BMC Pregnancy and Childbirth.

“The purpose of this study was to look at possible mechanisms between neighborhood stressors and pregnancy health, and we looked at sex steroid hormones because they’re critically important for both fetal development and maternal health,” Rivera-Núñez said.

Researchers analyzed data from 262 pregnant women who completed a questionnaire about their neighborhoods and underwent blood tests that measured sex hormones such as testosterone in each trimester.

The researchers found that women living in neighborhoods with stressors such as vacant lots, derelict buildings and other signs of disorder had significantly higher levels of testosterone – nearly 40 percent higher by the third trimester of pregnancy – than women living in well-ordered neighborhoods.

Testosterone is known to play a role in a variety of pregnancy-related processes, including sexual differentiation of the brain during early development.

Megan Hansel, first author and doctoral student at the Rutgers School of Public Health, said their findings suggest interventions to reduce neighborhood stress, such as improving access to green spaces and community resources, could help to improve pregnancy outcomes for all pregnant people.

In addition to the potential physical health risks for pregnant people and their babies, neighborhood stress also can harm maternal mental health, previous studies show. Pregnant people living in stressful neighborhoods are more likely to experience anxiety, depression and other mental health problems. These mental health problems also can hurt pregnancy outcomes.

Data for the study come from the Understanding Pregnancy Signals and Infant Development (UPSIDE) cohort, which collected biospecimens, questionnaires and medical record data from 262 women living in and around Rochester, N.Y. Researchers measured the sex hormones maternal serum total testosterone, free testosterone, estrone, estradiol and estriol in each trimester and surveyed participants about neighborhood stressors. UPSIDE is part of the NIH program Environmental Influences on Child Health Outcomes (ECHO), the largest study on child health in the U.S.

The new analysis of UPSIDE data found that 73 percent of women in the cohort reported exposure to one or more types of neighborhood disorder, while 22 percent reported any exposure to violence.

In adjusted models, neighborhood disorder was associated with higher testosterone across pregnancy, with the strongest associations observed in the third trimester, where neighborhood disorder was associated with an average testosterone elevation of 38 percent. The effect was more pronounced in women carrying male rather than female fetuses.

Exposure to violence wasn’t associated with any hormones.

“The findings suggest that stress may alter prenatal testosterone levels, which could explain some of the adverse outcomes we find when pregnant people live with neighborhood stressors,” Rivera Núñez said. “But more research is needed to prove a causal link.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Are results from clinical trials in kidney transplant recipients applicable to the real world?

2023-11-03
Highlights Investigators have found demographic differences between participants of kidney transplant clinical trials and transplant recipients in the United States, even in recent years. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Investigators recently examined the extent to which participants in clinical trials related to kidney transplantation are similar to individuals undergoing transplantation in the United States. The ...

County-level structural racism may affect mortality rates in people with kidney failure

2023-11-03
Highlights In a recent analysis of US data, Black patients with kidney failure experienced survival advantages compared with White patients when county-level structural racism was low, but they experienced survival disadvantages compared with White patients at higher levels of structural racism. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — A new analysis indicates that county-level structural racism is a significant determinant of death among individuals ...

Is high urinary albumin linked to sub-clinical cardiovascular disease in people with type 2 diabetes?

2023-11-03
Highlights Imaging tests in individuals with type 2 diabetes without symptoms of cardiovascular disease indicated that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary artery microcalcifications. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Advances in non-invasive imaging have allowed clinicians to assess both the structure and function of coronary arteries. Investigators who recently used positron emission tomography and computed tomography ...

Scientists create the most complete atlas of the human fetal kidney to date

2023-11-03
Highlights By examining the gene expression patterns of single cells from human fetal kidneys, researchers created a map that demonstrates the trajectories of cell states in the developing kidney and that identifies characteristics associated with kidney diseases. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Scientists have examined the gene expression patterns of single cells from 5 human fetal kidneys to create the most complete atlas of the ...

Sotagliflozin protects kidney and heart in patients with type 2 diabetes and chronic kidney disease

2023-11-03
Highlights Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type 2 diabetes and chronic kidney disease. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 3, 2023) — Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes. An exploratory analysis ...

HAARP artificial airglow may be widely visible in Alaska

2023-11-03
Alaskans and visitors may be able to see an artificial airglow in the sky created by the High-frequency Active Auroral Research Program during a four-day research campaign that starts Saturday. Scientists from the University of Alaska Fairbanks, Cornell University, University of Colorado Denver, University of Florida and Georgia Institute of Technology will conduct a variety of experiments at the UAF-operated research site. The experiments will focus on the ionosphere, the region of the atmosphere between about 30 and 350 miles ...

Management of recurrent gastrointestinal cancer with ripretinib and surgery

Management of recurrent gastrointestinal cancer with ripretinib and surgery
2023-11-03
“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.” BUFFALO, NY- November 3, 2023 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.” Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced ...

Transforming the food system to serve all

2023-11-03
Health happens where people work, live, play and worship, says Prof. Stacey Snelling, chair of the Department of Health Studies in American University’s College of Arts and Sciences. And that’s where the Healthy Schools, Healthy Communities Lab engages children, adults and older adults to tackle health inequities. Snelling received a three-year grant of $2.8 million from Novo Nordisk Inc. for health education and to grow the number of Black farmers producing locally grown fruit and vegetables. The goal is to improve local ...

Oncology researchers raise ethics concerns posed by patient-facing Artificial Intelligence

2023-11-03
BOSTON – Ready or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, find support, and more. In a new paper in JCO Oncology Practice, bioethics researchers at Dana-Farber Cancer Institute call on medical societies, government leaders, clinicians, and researchers to work together to ensure AI-driven healthcare preserves patient autonomy and respects human dignity. The authors note that while AI has immense potential for expanding access to cancer care and improving the ...

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

2023-11-03
Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 2 in the Journal of Clinical Oncology. The radiopharmaceutical 225AC-J591 was administered in a single injection and consists of two parts: an antibody that helps find the cancer cells is linked to a molecule that delivers a deadly dose of radiation. Specifically, an antibody named J591 that ...

LAST 30 PRESS RELEASES:

Fossils from the Adriatic Sea show a recent and worrying reversal of fortunes

With curtailed carbon emissions, corals can survive climate change

Global prevalence of short-sightedness in children and teens set to top 740 million cases by 2050

Urgent rethink of bottled water’s huge and growing toll on human and planetary health

Women still missing out on treatment for their No 1 killer—cardiovascular disease

Palestinian education ‘under attack’, leaving a generation close to losing hope, study warns

Semaglutide improves outcomes for obese patients with common skin condition, new study shows

Could GLP1RA drugs lower high iron levels?

C-Path’s PKD outcomes consortium receives BAA Award for project to advance drug development tools for autosomal dominant tubulointerstitial kidney disease

New insights into hot carrier solar cells: Increasing generation and extraction

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

How emotion boosts memory for context

Specially designed video games may benefit mental health of children and teenagers

President Obama 2012 reelection linked to significantly better mental health in Black men — but only those with a college education

Finding the sweet spot: Machine learning reveals factors for successful crowdfunding

University of Houston unveils guideline to enhance treatment access for opioid use disorder in community pharmacies

Atmospheric methane increase during pandemic due primarily to wetland flooding

Violence, harassment from students is overwhelmingly ‘part of the job’ for Saskatchewan education sector workers

Thermal effects in spintronics systematically assessed for first time

Study shows rates of e-bike injuries rise fourfold and powered scooter injuries nearly double

Prediabetes during adolescence and young adulthood linked with likelihood of adverse pregnancy outcomes

Researchers discover new role of immune cells in eye health

Daniel R. Larson to receive 2025 Carolyn Cohen Innovation Award

James A. Glazier to receive 2025 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award

Better together: Gut microbiome communities’ resilience to drugs

More to munch on: The popcorn planet WASP-107b unveils new atmospheric details

Innovative electrolytes could transform steelmaking and beyond

Planting seeds for safer farming

Fruit-only diet improves bats’ immune response to viruses

Placebo pain relief and positive treatment expectations are not caused by dopamine

[Press-News.org] Neighborhood stressors dangerously elevate pregnancy hormones